Product image of Hydroxycarbamid Hexal (Hydroxycarbamide) supplied by GNH India

Hydroxycarbamid Hexal

Active Ingredient:
Hydroxycarbamide
Origin:
EU

Hydroxycarbamid Hexal (Hydroxycarbamide)

Hydroxycarbamide, the active ingredient in Hydroxycarbamid Hexal, is an antimetabolite presented as an oral formulation for oral use. It is employed in the management of sickle cell disease and several hematologic malignancies, including chronic myelogenous leukemia, polycythemia vera, essential thrombocythemia, and melanoma.

GNH India supplies Hydroxycarbamid Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Manufacturer / TM Owner

Novartis Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Hydroxycarbamid Hexal is used to treat diseases within the hematologic and oncologic spectrum.

  • Sickle cell disease: reduces frequency of vaso‑occlusive crises and improves hemoglobin levels.
  • Chronic myelogenous leukemia: helps control disease progression as part of targeted therapy regimens.
  • Polycythemia vera: lowers elevated red blood cell mass and decreases thrombotic risk.
  • Essential thrombocythemia: reduces platelet counts and mitigates clotting complications.
  • Melanoma: used as an adjunct in certain treatment protocols to inhibit tumor growth.

How It Works

  • Hydroxycarbamide inhibits the enzyme ribonucleotide reductase, which is essential for the conversion of ribonucleotides to deoxyribonucleotides. By limiting deoxyribonucleotide pools, the drug impairs DNA synthesis and repair, leading to reduced proliferation of rapidly dividing cells such as malignant hematopoietic clones and sickled erythrocytes. This antimetabolite effect underlies its therapeutic activity in both neoplastic and non‑malignant hematologic conditions.

Side Effects

Hydroxycarbamid Hexal may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Fatigue: persistent tiredness.
  • Hair loss: temporary thinning or shedding.
  • Gastrointestinal discomfort: abdominal pain or diarrhea.

Serious or Rare Side Effects

  • Bone marrow suppression: leading to severe anemia, neutropenia, or thrombocytopenia.
  • Liver toxicity: elevated transaminases or hepatitis.
  • Severe allergic reactions: rash, swelling, or anaphylaxis.

Precautions & Warnings

When prescribing Hydroxycarbamid Hexal, clinicians should observe several safety precautions.

  • Monitor blood counts: perform regular CBC to detect myelosuppression.
  • Assess renal function: adjust use in patients with impaired kidney function.
  • Avoid in known hypersensitivity: discontinue if allergic reaction occurs.
  • Use contraception: advise patients of reproductive potential to prevent fetal exposure.
  • Review concomitant myelosuppressive drugs: avoid additive bone‑marrow toxicity.
  • Store at below 25°C: keep in the original packaging, protect from moisture and heat.

Avoid Interactions

Hydroxycarbamid Hexal can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid)

  • Concurrent myelosuppressive chemotherapy: may cause profound bone‑marrow suppression.
  • Live vaccines: increased risk of infection due to immunosuppression.
  • Allopurinol: can enhance hydroxycarbamide toxicity.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may increase risk of gastrointestinal irritation.
  • Antacids containing aluminum or magnesium: can reduce hydroxycarbamide absorption.
  • Penicillins and cephalosporins: may affect renal clearance.
  • Azathioprine: additive immunosuppressive effect.

Frequently Asked Questions

Hydroxycarbamid Hexal is indicated for sickle cell disease and several hematologic cancers, including chronic myelogenous leukemia, polycythemia vera, essential thrombocythemia, and melanoma. It helps control disease activity, reduce complications, and improve patient outcomes in these disorders.

Hydroxycarbamide blocks ribonucleotide reductase, an enzyme required to produce deoxyribonucleotides for DNA synthesis. By depleting these building blocks, the drug slows DNA replication, limiting the growth of rapidly dividing cells such as abnormal blood cells and certain tumor cells.

The dose of Hydroxycarbamid Hexal is individualized by the prescribing healthcare professional based on the specific indication, patient weight, disease severity, and laboratory monitoring results. No fixed regimen is provided here; the prescriber sets the appropriate dosage.

Safety data for hydroxycarbamide in pregnancy and lactation are limited, and the drug may pose risks to the fetus or infant. It should only be used if the potential benefit justifies the potential risk, and a healthcare provider should be consulted before use in these populations.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Hydroxycarbamid Hexal (hydroxycarbamide) is an established antimetabolite that offers oral administration and a well‑characterised safety profile. Compared with newer targeted agents, it may be less expensive but requires regular blood‑count monitoring. Choice of therapy depends on disease specifics, patient factors and clinical guidelines.

Store Hydroxycarbamid Hexal at below 25 °C in its original packaging, protecting it from moisture, direct sunlight and excessive heat. Do not store in a bathroom or near a kitchen sink where humidity is high.

Hydroxycarbamid Hexal is taken orally, usually with a full glass of water. The exact timing (with food or on an empty stomach) and frequency are determined by the prescribing clinician based on the individual treatment plan.

The most serious risks include severe bone‑marrow suppression leading to anemia, neutropenia or thrombocytopenia, liver toxicity, and rare but life‑threatening allergic reactions such as anaphylaxis. Patients should be monitored regularly for these complications.

Hydroxycarbamid Hexal should be avoided in individuals with known hypersensitivity to hydroxycarbamide or any excipients, in patients with severe renal or hepatic impairment unless dose‑adjusted, and in those receiving live vaccines or other myelosuppressive therapies without careful medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Hydroxycarbamide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT